Interojo Inc. (KOSDAQ:119610)
18,970
+580 (3.15%)
At close: Mar 20, 2026
Interojo Market Cap
Interojo has a market cap or net worth of 216.52 billion as of March 20, 2026. Its market cap has decreased by -37.74% in one year.
Market Cap
216.52B
Enterprise Value
245.48B
Revenue
109.28B
Ranking
n/a
PE Ratio
74.18
Stock Price
18,970.00
Market Cap Chart
Since July 28, 2010, Interojo's market cap has increased from 44.29B to 216.52B, an increase of 388.88%. That is a compound annual growth rate of 10.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 216.52B | 18.49% |
| Dec 30, 2025 | 182.73B | -53.77% |
| Dec 28, 2023 | 395.31B | 11.81% |
| Dec 29, 2022 | 353.55B | -0.83% |
| Dec 30, 2021 | 356.49B | 45.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.11T |
| Celltrion | 44.21T |
| Sam Chun Dang Pharm. | 21.09T |
| ALTEOGEN | 18.91T |
| Daewon Pharmaceutical | 223.34B |
| HLB Pharmaceutical | 222.43B |
| Vieworks | 216.70B |
| Samil Pharmaceutical Co.,Ltd | 213.36B |